Biocept Inc financial data

Symbol
BIOCQ on OTC
Industry
Services-Medical Laboratories
Location
9955 Mesa Rim Road, San Diego, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q2 2023 - Aug 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 280 % -26.7%
Quick Ratio 17.8 % -24.2%
Debt-to-equity 296 % +333%
Return On Equity -412 % -817%
Return On Assets -104 % -290%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.63M shares -84.5%
Common Stock, Shares, Outstanding 2.41M shares -85.8%
Entity Public Float 15.9M USD -73.5%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 1.04M shares +83.9%
Weighted Average Number of Shares Outstanding, Diluted 1.04M shares +83.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.36M USD -97.6%
Cost of Revenue 15.7M USD -60.5%
Research and Development Expense 4.04M USD -36.5%
Selling and Marketing Expense 2.78M USD -71.6%
General and Administrative Expense 12M USD -28.3%
Costs and Expenses 34.5M USD -52.4%
Operating Income (Loss) -33.2M USD -116%
Nonoperating Income (Expense) 2.42M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -30.7M USD -95.5%
Income Tax Expense (Benefit) -125K USD -200%
Net Income (Loss) Attributable to Parent -30.6M USD -93.1%
Earnings Per Share, Basic 12.2 USD/shares +80.4%
Earnings Per Share, Diluted 12.2 USD/shares +80.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 800K USD -93.6%
Inventory, Net 551K USD -75.5%
Assets, Current 8.86M USD -77.3%
Property, Plant and Equipment, Net 2.4M USD -11.3%
Operating Lease, Right-of-Use Asset 8.19M USD -6.49%
Other Assets, Noncurrent 386K USD -22.2%
Assets 22.1M USD -58.6%
Accounts Payable, Current 1.47M USD -69.6%
Employee-related Liabilities, Current 792K USD
Accrued Liabilities, Current 1.53M USD -44.1%
Liabilities, Current 4.9M USD -49%
Operating Lease, Liability, Noncurrent 8.85M USD -6.48%
Liabilities 21.8M USD -15.1%
Retained Earnings (Accumulated Deficit) -309M USD -11%
Stockholders' Equity Attributable to Parent 290K USD -99%
Liabilities and Equity 22.1M USD -58.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.19M USD -565%
Net Cash Provided by (Used in) Financing Activities 162K USD
Net Cash Provided by (Used in) Investing Activities -91K USD +7.14%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 2.41M shares -85.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.12M USD -372%
Interest Paid, Excluding Capitalized Interest, Operating Activities 46K USD -24.6%
Deferred Tax Assets, Valuation Allowance 29.9M USD +29.4%
Deferred Tax Assets, Gross 33M USD +25.2%
Operating Lease, Liability 9.41M USD -5.21%
Payments to Acquire Property, Plant, and Equipment 91K USD -7.14%
Lessee, Operating Lease, Liability, to be Paid 14.5M USD -9.99%
Property, Plant and Equipment, Gross 8.72M USD +13.9%
Operating Lease, Liability, Current 565K USD +20.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.72M USD +2.57%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.67M USD +2.64%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.07M USD -17.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.76M USD +2.74%
Deferred Tax Assets, Operating Loss Carryforwards 23.6M USD +27.7%
Preferred Stock, Shares Issued 2.09K shares -0.76%
Current Income Tax Expense (Benefit) -125K USD -200%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.82M USD +3.89%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.81M USD +2.44%
Operating Lease, Payments 406K USD +2.53%
Additional Paid in Capital 307M USD
Preferred Stock, Shares Outstanding 2.09K shares -0.76%
Current State and Local Tax Expense (Benefit) -125K USD -200%
Interest Expense 50K USD -67.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%